Blue Crest Capital Management LTD Neogenomics Inc Transaction History
Blue Crest Capital Management LTD
- $1.62 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$277 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$97.1 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$93 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$92.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.77B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...